Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
14.13
+0.56 (4.17%)
Aug 14, 2025, 11:39 AM - Market open
Mineralys Therapeutics Market Cap
Mineralys Therapeutics has a market cap or net worth of $920.60 million as of August 14, 2025. Its market cap has increased by 44.52% in one year.
Market Cap
920.60M
Enterprise Value
540.75M
1-Year Change
44.52%
Ranking
Category
Stock Price
$14.13
Market Cap Chart
Since the IPO on February 10, 2023, Mineralys Therapeutics's market cap has increased from $624.91M to $920.60M, an increase of 47.32%. That is a compound annual growth rate of 16.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 883.78M | 44.25% |
| Dec 31, 2024 | 612.65M | 73.31% |
| Dec 29, 2023 | 353.50M | -43.43% |
| Feb 10, 2023 | 624.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |